Reconstitution of Natural Killer Cell Receptor Repertoires after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation: Analyses of CD94:NKG2A and Killer Immunoglobulin-Like Receptor Expression and Their Associations with Clinical Outcome

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 6, 2007, Pages 734-744

  Zhao, Xiang Yu ^a   Huang, Xiao Jun ^a   Liu, Kai Yan ^a   Xu, Lan Ping ^a   Liu, Dai Hong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

CD94:NKG2A; GVHD; Haploidentical; HLA mismatched; HSCT; KIRs

Indexed keywords

ANTIGEN; BUSULFAN; CD158A ANTIGEN; CD158B ANTIGEN; CD158E ANTIGEN; CD94 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEMUSTINE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HAPLOIDY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LINEAR REGRESSION ANALYSIS; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; ANTIGENS, CD94; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RECEPTORS, IMMUNOLOGIC; REGENERATION; TREATMENT OUTCOME;

EID: 34248667638     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.02.010     Document Type: Article

References (21)

1. Farag S.S., Fehniger T.A., Ruggeri L., Velardi A., and Caligiuri M.A. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100 (2002) 1935-1947
2. Bishara A., De Santis D., Witt C.C., et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 63 (2004) 204-211
3. Bornhauser M., Schwerdtfeger R., Martin H., et al. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors [2] (multiple letters). Blood 103 (2004) 2860-2862
4. Davies S.M., Ruggieri L., DeFor T., et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 100 (2002) 3825-3827
5. Farag S.S., Bacigalupo A., Eapen M., et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry. Biol Blood Marrow Transplant 12 (2006) 876
6. Giebel S., Locatelli F., Lamparelli T., et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 (2003) 814-819
7. Huang X.J., Zhao X.Y., Liu D.H., Liu K.Y., and Xu L.P. Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion. Leukemia 21 (2007) 848-851
8. Lowe E.J., Turner V., Handgretinger R., et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol 123 (2003) 323-326
9. Ruggeri L., Capanni M., Casucci M., et al. Role Of natural killer cell alloreactivity in hla-mismatched hematopoietic stem cell transplantation. Blood 94 (1999) 333-339
10. Zhao X.Y., Huang X.J., Liu K.Y., Xu L.P., and Liu D.H. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients. Eur J Hematol 78 (2007) 338-346
11. Cooley S., McCullar V., Wangen R., et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 106 (2005) 4370-4376
12. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., and Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 101 (2003) 3730-3740
13. Nguyen S., Dhedin N., Vernant J.P., et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105 (2005) 4135-4142
14. Lu D.P., Dong L., Wu T., et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107 (2006) 3065-3073
15. Huang X.J., Liu D.H., Liu K.Y., et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 38 (2006) 291-297
16. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18 (1974) 295-230
17. Ruggeri L., Capanni M., Mancusi A., et al. Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Int J Hematol 81 (2005) 13-17
18. Miller J.S., and McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 98 (2001) 705-713
19. Shilling H.G., Young N., Guethlein L.A., et al. Genetic control of human NK cell repertoire. J Immunol 169 (2002) 239-247
20. Vitale M., Della Chiesa M., Carlomagno S., et al. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-(gamma) production upon interaction with dendritic cells. Eur J Immunol 34 (2004) 1715-1722
21. Borrego F., Robertson M.J., Ritz J., Pena J., and Solana R. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology 97 (1999) 159-165